Corbin Therapeutics is a spin-off company from AmorChem Fund 1, developing a sophisticated in-vivo genome-wide screening platform in mice undergoing experimental neuro-inflammation, from the laboratory of Dr Philippe Gros, Faculty of Medicine, McGill University, leading to a novel anti-inflammatory target in the deubiquitinylation (DUB) family of enzymes, more particularly USP15.
View Top Employees from Corbin Therapeutics Inc| Website | http://www.corbinthera.com |
| Revenue | $5 million |
| Employees | 2 (0 on RocketReach) |
| Founded | 2016 |
| Address | 4 Westmount Square, 160, Westmount, Quebec H3Z 2S6, CA |
| Phone | (514) 825-9035 |
| Technologies |
JavaScript,
HTML,
PHP
+8 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Business Services General, Business Services, Science and Engineering, Social/Platform Software, Therapeutics, Health Care |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies |
Looking for a particular Corbin Therapeutics Inc employee's phone or email?
Corbin Therapeutics Inc Questions
The Corbin Therapeutics Inc annual revenue was $5 million in 2024.
Corbin Therapeutics Inc is based in Westmount, Quebec.
The NAICS codes for Corbin Therapeutics Inc are [54, 5417, 54171, 541, 541714].
The SIC codes for Corbin Therapeutics Inc are [87, 873].
Related Companies
